Information maintained by the Legislative Reference Bureau
Updating the database of the Illinois Compiled Statutes (ILCS) is an ongoing process. Recent laws may not yet be included in the ILCS database, but they are found on this site as Public Acts soon after they become law. For information concerning the relationship between statutes and Public Acts, refer to the Guide.

Because the statute database is maintained primarily for legislative drafting purposes, statutory changes are sometimes included in the statute database before they take effect. If the source note at the end of a Section of the statutes includes a Public Act that has not yet taken effect, the version of the law that is currently in effect may have already been removed from the database and you should refer to that Public Act to see the changes made to the current law.

PUBLIC HEALTH
(410 ILCS 460/) Sickle Cell Prevention, Care, and Treatment Program Act.

410 ILCS 460/Art. 1

 
    (410 ILCS 460/Art. 1 heading)
Article 1.
(Uncodified provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 5

 
    (410 ILCS 460/Art. 5 heading)
Article 5.
(The Community Health Worker Certification and Reimbursement Act is compiled at 410 ILCS 67/)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 10

 
    (410 ILCS 460/Art. 10 heading)
Article 10.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 15

 
    (410 ILCS 460/Art. 15 heading)
Article 15.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 20

 
    (410 ILCS 460/Art. 20 heading)
Article 20.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 35

 
    (410 ILCS 460/Art. 35 heading)
Article 35.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 45

 
    (410 ILCS 460/Art. 45 heading)
Article 45.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 50

 
    (410 ILCS 460/Art. 50 heading)
Article 50.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 60

 
    (410 ILCS 460/Art. 60 heading)
Article 60.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 65

 
    (410 ILCS 460/Art. 65 heading)
Article 65.
(The Behavioral Health Workforce Education Center of Illinois Act is compiled at 110 ILCS 185/)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 70

 
    (410 ILCS 460/Art. 70 heading)
Article 70.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 72

 
    (410 ILCS 460/Art. 72 heading)
Article 72.
(The Underlying Causes of Crime and Violence Study Act is compiled at 410 ILCS 165/)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 80

 
    (410 ILCS 460/Art. 80 heading)
Article 80.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 90

 
    (410 ILCS 460/Art. 90 heading)
Article 90.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 95

 
    (410 ILCS 460/Art. 95 heading)
Article 95.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 100

 
    (410 ILCS 460/Art. 100 heading)
Article 100.
(The Special Commission on Gynecologic Cancers Act is compiled at 20 ILCS 5170/)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 105

 
    (410 ILCS 460/Art. 105 heading)
Article 105.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 110

 
    (410 ILCS 460/Art. 110 heading)
Article 110.
(The Racial Impact Note Act is compiled at 25 ILCS 83/)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 115

 
    (410 ILCS 460/Art. 115 heading)
Article 115.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 120

 
    (410 ILCS 460/Art. 120 heading)
Article 120.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 125

 
    (410 ILCS 460/Art. 125 heading)
Article 125.
(The Health and Human Services Task Force and Study Act is compiled at 20 ILCS 5175/)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 130

 
    (410 ILCS 460/Art. 130 heading)
Article 130.
(The Anti-Racism Commission Act is compiled at 20 ILCS 5180/)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 131

 
    (410 ILCS 460/Art. 131 heading)
Article 131.

(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/131-1

    (410 ILCS 460/131-1)
    Sec. 131-1. Short title. This Article may be cited as the Sickle Cell Prevention, Care, and Treatment Program Act. References in this Article to "this Act" mean this Article.
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/131-5

    (410 ILCS 460/131-5)
    Sec. 131-5. Definitions. As used in this Act:
    "Department" means the Department of Public Health.
    "Program" means the Sickle Cell Prevention, Care, and Treatment Program.
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/131-10

    (410 ILCS 460/131-10)
    Sec. 131-10. Sickle Cell Prevention, Care, and Treatment Program. The Department shall establish a grant program for the purpose of providing for the prevention, care, and treatment of sickle cell disease and for educational programs concerning the disease.
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/131-15

    (410 ILCS 460/131-15)
    Sec. 131-15. Grants; eligibility standards.
    (a) The Department shall do the following:
        (1)(A) Develop application criteria and standards of
    
eligibility for groups or organizations who apply for funds under the program.
        (B) Make available grants to groups and organizations
    
who meet the eligibility standards set by the Department. However:
            (i) the highest priority for grants shall be
        
accorded to established sickle cell disease community-based organizations throughout Illinois; and
            (ii) priority shall also be given to ensuring the
        
establishment of sickle cell disease centers in underserved areas that have a higher population of sickle cell disease patients.
        (2) Determine the maximum amount available for each
    
grant provided under subparagraph (B) of paragraph (1).
        (3) Determine policies for the expiration and renewal
    
of grants provided under subparagraph (B) of paragraph (1).
        (4) Require that all grant funds be used for the
    
purpose of prevention, care, and treatment of sickle cell disease or for educational programs concerning the disease. Grant funds shall be used for one or more of the following purposes:
            (A) Assisting in the development and expansion of
        
care for the treatment of individuals with sickle cell disease, particularly for adults, including the following types of care:
                (i) Self-administered care.
                (ii) Preventive care.
                (iii) Home care.
                (iv) Other evidence-based medical procedures
            
and techniques designed to provide maximum control over sickling episodes typical of occurring to an individual with the disease.
            (B) Increasing access to health care for
        
individuals with sickle cell disease.
            (C) Establishing additional sickle cell disease
        
infusion centers.
            (D) Increasing access to mental health resources
        
and pain management therapies for individuals with sickle cell disease.
            (E) Providing counseling to any individual, at no
        
cost, concerning sickle cell disease and sickle cell trait, and the characteristics, symptoms, and treatment of the disease.
                (i) The counseling described in this
            
subparagraph (E) may consist of any of the following:
                    (I) Genetic counseling for an individual
                
who tests positive for the sickle cell trait.
                    (II) Psychosocial counseling for an
                
individual who tests positive for sickle cell disease, including any of the following:
                        (aa) Social service counseling.
                        (bb) Psychological counseling.
                        (cc) Psychiatric counseling.
        (5) Develop a sickle cell disease educational
    
outreach program that includes the dissemination of educational materials to the following concerning sickle cell disease and sickle cell trait:
            (A) Medical residents.
            (B) Immigrants.
            (C) Schools and universities.
        (6) Adopt any rules necessary to implement the
    
provisions of this Act.
    (b) The Department may contract with an entity to implement the sickle cell disease educational outreach program described in paragraph (5) of subsection (a).
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/131-20

    (410 ILCS 460/131-20)
    Sec. 131-20. Sickle Cell Chronic Disease Fund.
    (a) The Sickle Cell Chronic Disease Fund is created as a special fund in the State treasury for the purpose of carrying out the provisions of this Act and for no other purpose. The Fund shall be administered by the Department. Expenditures from the Fund shall be subject to appropriation.
    (b) The Fund shall consist of:
        (1) Any moneys appropriated to the Department for the
    
Sickle Cell Prevention, Care, and Treatment Program.
        (2) Gifts, bequests, and other sources of funding.
        (3) All interest earned on moneys in the Fund.
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/131-25

    (410 ILCS 460/131-25)
    Sec. 131-25. Study.
    (a) Before July 1, 2022, and on a biennial basis thereafter, the Department, with the assistance of:
        (1) the Center for Minority Health Services;
        (2) health care providers that treat individuals with
    
sickle cell disease;
        (3) individuals diagnosed with sickle cell disease;
        (4) representatives of community-based organizations
    
that serve individuals with sickle cell disease; and
        (5) data collected via newborn screening for sickle
    
cell disease;
shall perform a study to determine the prevalence, impact, and needs of individuals with sickle cell disease and the sickle cell trait in Illinois.
    (b) The study must include the following:
        (1) The prevalence, by geographic location, of
    
individuals diagnosed with sickle cell disease in Illinois.
        (2) The prevalence, by geographic location, of
    
individuals diagnosed as sickle cell trait carriers in Illinois.
        (3) The availability and affordability of screening
    
services in Illinois for the sickle cell trait.
        (4) The location and capacity of the following for
    
the treatment of sickle cell disease and sickle cell trait carriers:
            (A) Treatment centers.
            (B) Clinics.
            (C) Community-based social service organizations.
            (D) Medical specialists.
        (5) The unmet medical, psychological, and social
    
needs encountered by individuals in Illinois with sickle cell disease.
        (6) The underserved areas of Illinois for the
    
treatment of sickle cell disease.
        (7) Recommendations for actions to address any
    
shortcomings in the State identified under this Section.
    (c) The Department shall submit a report on the study performed under this Section to the General Assembly.
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/131-30

    (410 ILCS 460/131-30)
    Sec. 131-30. Implementation subject to appropriation. Implementation of this Act is subject to appropriation.
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/131-90

    (410 ILCS 460/131-90)
    Sec. 131-90. (Amendatory provisions; text omitted).
(Source: P.A. 102-4, eff. 4-27-21; text omitted.)

410 ILCS 460/Art. 135

 
    (410 ILCS 460/Art. 135 heading)
Article 135.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 150

 
    (410 ILCS 460/Art. 150 heading)
Article 150.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 155

 
    (410 ILCS 460/Art. 155 heading)
Article 155.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 160

 
    (410 ILCS 460/Art. 160 heading)
Article 160.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 170

 
    (410 ILCS 460/Art. 170 heading)
Article 170.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 172

 
    (410 ILCS 460/Art. 172 heading)
Article 172.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 175

 
    (410 ILCS 460/Art. 175 heading)
Article 175.
(Amendatory provisions; text omitted)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 185

 
    (410 ILCS 460/Art. 185 heading)
Article 185.
(The Medicaid Technical Assistance Act is compiled at 305 ILCS 75/)
(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/Art. 999

 
    (410 ILCS 460/Art. 999 heading)
Article 999.

(Source: P.A. 102-4, eff. 4-27-21.)

410 ILCS 460/999-99

    (410 ILCS 460/999-99)
    Sec. 999-99. Effective date. This Act takes effect upon becoming law.
(Source: P.A. 102-4, eff. 4-27-21.)